News Medical on MSN
Genome-edited immune cell therapy shows promise for treating aggressive blood cancer
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
Illumina, Commercial Metals and Newmont have all seen broker upgrades, signaling bullish momentum amid market uncertainties.
Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...
ASUS Republic of Gamers (ROG) today announced that it is set to unveil the next chapter in gaming at its virtual launch event, CES 2026 ROG ? Dare to Innovate. The showcase will stream globally via ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...
Investor's Business Daily on MSN
Dow Jones futures: Techs rise as AI giants, Fed loom; Tesla, Broadcom early movers
The market rally toward highs continues, with Tesla among stocks in buy areas. A Fed meeting and AI giants loom.
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...
The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results